Literature DB >> 6813006

Effects of urethane-chloralose anaesthesia on respiration in the rat.

E W Hughes, R L Martin-Body, I H Sarelius, J D Sinclair.   

Abstract

1. Respiratory effects were measured in rats during six hours' anaesthesia with urethane and chloralose. 2. One-hundred min from urethane administration, minute ventilation (VE) was minimal, arterial PO2 was low, arterial PCO2 was high; tidal volume (VT) and respiratory frequency (f) were relatively constant; hypercarbic and hypoxic responses were substantial. 3. Between 100 and 400 min from urethane administration, minute ventilation and frequency increased and became more variable, tidal volume remained relatively constant, arterial PO2 rose to 100 mmHg, PCO2 fell to 37 mmHg; hypercarbic sensitivity increased and hypoxic sensitivity decreased. 4. We conclude that the anaesthetic regime produced initial depression of respiration relative to metabolism but without great loss of respiratory chemosensitivity. The respiratory depression was prolonged by increased dosage with urethane and chloralose. 5. The variations between hypercarbic and hypoxic responses confirm that they operate through separate mechanisms.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6813006     DOI: 10.1111/j.1440-1681.1982.tb00788.x

Source DB:  PubMed          Journal:  Clin Exp Pharmacol Physiol        ISSN: 0305-1870            Impact factor:   2.557


  3 in total

1.  Isoflurane, ketamine-xylazine, and urethane markedly alter breathing even at subtherapeutic doses.

Authors:  Cory A Massey; George B Richerson
Journal:  J Neurophysiol       Date:  2017-07-26       Impact factor: 2.714

2.  The effect of a ventral medial hypothalamic lesion on the insulin-induced hypotensive response in normal rats.

Authors:  J Wright-Richey; S Schultz-Klarr; J C Dunbar
Journal:  Acta Diabetol       Date:  1994-06       Impact factor: 4.280

3.  Glucose turnover in normal and diabetic rats under anesthesia.

Authors:  Z Madar
Journal:  Acta Diabetol Lat       Date:  1986 Jan-Mar
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.